Trial Profile
A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 400 mg/Day Lacosamide Tablets in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2017
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 02 Jul 2008 New trial record.
- 24 Jun 2008 Preliminary results reported in a UCB media release.